The weight-loss journey for a growing number of Australians using "miracle" medications must include exercise or risk ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

LAHORE: Punjab Chief Minister Maryam Nawaz on Thursday directed the preparation of a revised medicines list for government ...

Both the new weight loss drugs and bariatric (weight loss) surgery improve body composition in patients with obesity by ...

President Donald Trump’s deals with pharmaceutical companies are likely to have only a limited impact on Americans’ drug ...

The Wolfe County woman was indicted Tuesday for a charge of fetal homicide, which prosecutors later moved to dismiss.

England's NICE is recommending natalizumab, sold as Tysabri and Tyruko, as an NHS-covered treatment option for people with ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

NICE has recommended Tysabri and biosimilar Tyruko as an option for patients with highly active relapsing-remitting multiple ...

A new study proved ADHD stimulants do not improve attention but stimulate other parts of the brain. If children don't obtain enough sleep, they may exhibit symptoms similar to ADHD.

It will be available as an option for people with relapsing-remitting MS (RRMS), the most common form of the condition which ...